misiu143.. What I find even MORE surprising..Is the Deafening Silence from the FDA on our Phase 2 Study..
The FDA could have had us do a Study of a 150 patients with an Interim analysis at 75 patients.. We would have completed the 150 patient enrollment by now..While they pondered over the FINAL results we gave them a week ago of the 85 completed patients..
Does the FDA know we have a Pandemic on our hands..???
Market Data 
Markets 
AI
